Malignant ovarian germ cell tumors: Presentation, survival and second cancer in a population based Norwegian cohort (1953-2009)

Gynecologic Oncology

Volumn 131, Issue 2, 2013, Pages 330-335

  Solheim, O ^a   Kaern J ^a   Trope C G ^a,b   Rokkones, E ^a   Dahl, A A ^a,b   Nesland, J M ^a,b   Fossa S D ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cisplatin based chemotherapy; Malignant ovarian germ cell tumors; Second cancer; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CHORIOCARCINOMA; DISTANT METASTASIS; DYSGERMINOMA; EMBRYONAL CARCINOMA; FEMALE; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT OVARIAN GERM CELL TUMOR; MALIGNANT TERATOMA; MELANOMA; NORWAY; OVARY CANCER; PRIORITY JOURNAL; SECOND CANCER; UTERUS CANCER; YOLK SAC TUMOR;

CISPLATIN-BASED CHEMOTHERAPY; MALIGNANT OVARIAN GERM CELL TUMORS; SECOND CANCER; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CISPLATIN; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MORTALITY; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASMS, SECOND PRIMARY; NORWAY; OVARIAN NEOPLASMS; PROGNOSIS; REGISTRIES; YOUNG ADULT;

EID: 84886091379     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.08.028     Document Type: Article

References (21)

1. H.O. Smith, M. Berwick, and C.F. Verschraegen Incidence and survival rates for female malignant germ cell tumors Obstet Gynecol 107 2006 1075 1085
2. R.S. Arora, R.D. Alston, and T.O. Eden Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003 Cancer 118 2012 4290 4297
3. N. Murugaesu, P. Schmid, and G. Dancey Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment J Clin Oncol 24 2006 4862 4866
4. A. Stang, B. Trabert, and N. Wentzensen Gonadal and extragonadal germ cell tumours in the United States, 1973-2007 Int J Androl 35 2012 616 625
5. D.M. Gershenson Update on malignant ovarian germ cell tumors Cancer 71 4 Suppl. 1993 1581 1590
6. K.H. Lu, and D.M. Gershenson Update on the management of ovarian germ cell tumors J Reprod Med 50 2005 417 425
7. B.A. Warner, R.P. Monsaert, and P.G. Stumpf 46, XY gonadal dysgenesis: is oncogenesis related to H-Y phenotype or breast development? Hum Genet 69 1985 79 85
8. D.M. Gershenson Management of ovarian germ cell tumors J Clin Oncol 25 2007 2938 2943
9. J.N. Poynter, J.F. Amatruda, and J.A. Ross Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006 Cancer 116 2010 4882 4891
10. G. Mangili, C. Sigismondi, and A. Gadducci Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study Int J Gynecol Cancer 21 2011 1414 1421
11. I.B. Vergote, V.M. Abeler, and K.E. Kjørstad Management of malignant ovarian immature teratoma. Role of adriamycin Cancer 66 1990 882 886
12. O. Klepp, R. Klepp, and H. Host Combination chemotherapy of germ cell tumors of the testis with vincristine, adriamycin, cyclophosphamide, actinomycin D and medroxyprogesterone acetate Cancer 40 1977 638 646
13. D. Matei, J. Brown, and L. Frazier Updates in the management of ovarian germ cell tumors Am Soc Clin Oncol Educ Book 2013 2013 210 216
14. R.J. Kurman, and H.J. Norris Malignant germ cell tumors of the ovary Hum Pathol 8 1977 551 564
15. L.B. Travis, S.D. Fosså, and S.J. Schonfeld Second cancers among 40,576 testicular cancer patients: focus on long-term survivors J Natl Cancer Inst 97 2005 1354 1365
16. S.D. Fosså, N. Aass, and O.J. Kaalhus Testicular cancer in young Norwegians Surg Oncol 39 1988 43 63
17. M.F. Mitchell, D.M. Gershenson, and R.P. Soeters The long-term effects of radiation therapy on patients with ovarian dysgerminoma Cancer 67 1991 1084 1090
18. G. Mangili, G. Scarfone, and A. Gadducci Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9) Gynecol Oncol 119 2010 48 52
19. M.H. Greene Is cisplatin a human carcinogen? J Natl Cancer Inst 84 1992 306 312
20. L.B. Travis, E.J. Holowaty, and K. Bergfeldt Risk of leukemia after platinum-based chemotherapy for ovarian cancer N Engl J Med 340 1999 351 357
21. H. Host, and T. Stokke The treatment of malignant testicular tumors at the Norwegian Radium Hospital Cancer 12 1959 323 329